Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).

被引：0
|
作者：
Pellagatti, A
Giagounidis, A
Killick, S
Campbell, LJ
Wraight, V
Langford, CF
Fidler, C
Oscier, D
Aul, C
Wainscoat, JS
Boultwood, J
机构：
[1] John Radcliffe Hosp, LRF Mol Haematol Unit, Oxford OX3 9DU, England
[2] St Johannes Hosp, Med Klin 2, Duisburg, Germany
[3] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England
[4] Sanger Inst, Microarray Facil, Cambridge, England
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2363.2363
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2363
引用
收藏
页码：649A / 649A
页数：1
相关论文
共 50 条
  • [21] Expression profiling of CD34+cells in patients with myelodysplastic syndromes:: differences between early and advanced cases and analysis of apoptosis-related genes
    Pellagatti, A.
    Cazzola, M.
    Giagounidis, A.
    Malcovati, L.
    Della Porta, M. G.
    Jadersten, M.
    Killick, S.
    Fidler, C.
    Cattan, H.
    Bowen, D.
    Aul, C.
    Hellstrom-Lindberg, E.
    Wainscoat, J. S.
    Boultwood, J.
    LEUKEMIA RESEARCH, 2007, 31 : S35 - S35
  • [22] Expression profiling of CD34+cells in patients with myelodysplastic syndromes:: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
    Pellagatti, Andrea
    Cazzola, Mario
    Giagounidis, Aristoteles
    Malcovati, Luca
    Della Porta, Matteo G.
    Jadersten, Martin
    Killick, Sally
    Fidler, Carrie
    Oscier, David
    Bowen, David
    Aul, Carlo
    Helistrom-Lindberg, Eva
    Wainscoat, James S.
    Boultwood, Jacqueline
    BLOOD, 2006, 108 (11) : 742A - 742A
  • [23] Diagnostic potential of immunophenotyping CD34+cells in myelodysplastic syndromes.
    De Waele, Marc
    Leus, Barbara
    Trullemans, Fabienne
    Verschraegen, Inge
    Urbino, Montse
    Jochmans, Kristin
    Renmans, Wim
    BLOOD, 2006, 108 (11) : 294B - 294B
  • [24] Pleiotropic mechanisms of action of lenalidomide efficacy in del(5q) myelodysplastic syndromes
    Heise, Carla
    Carter, Troy
    Schafer, Peter
    Chopra, Rajesh
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (10) : 1663 - 1672
  • [25] Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations
    Mallo, Mar
    del Rey, Monica
    Ibanez, Mariam
    Jose Calasanz, Ma
    Arenillas, Leonor
    Jose Larrayoz, Ma
    Pedro, Carmen
    Jerez, Andres
    Maciejewski, Jaroslaw
    Costa, Dolors
    Nomdedeu, Meritxell
    Diez-Campelo, Maria
    Lumbreras, Eva
    Gonzalez-Martinez, Teresa
    Marugan, Isabel
    Such, Esperanza
    Cervera, Jose
    Cigudosa, Juan C.
    Alvarez, Sara
    Florensa, Lourdes
    Hernandez, Jesus Ma
    Sole, Francesc
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) : 74 - 86
  • [26] Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last?
    Vozella, Federico
    Latagliata, Roberto
    Carmosino, Ida
    Volpicelli, Paola
    Montagna, Chiara
    Romano, Angela
    Roberto, Amanda
    Finsinger, Paola
    Mancini, Marco
    Breccia, Massimo
    Oliva, Esther
    Alimena, Giuliana
    HEMATOLOGICAL ONCOLOGY, 2015, 33 (01) : 48 - 51
  • [27] CYTOGENETIC CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES (MDS) WITH ISOLATED DEL(5Q)
    Zemanova, Z.
    Michalova, K.
    Brezinova, J.
    Svobodova, K.
    Lhotska, H.
    Sarova, I.
    Lizcova, L.
    Izakova, S.
    Ransdorfova, S.
    Pavlistova, L.
    Berkova, A.
    Skipalova, K.
    Belickova, M.
    Siskova, M.
    Neuwirtova, R.
    Cermak, J.
    Stopka, T.
    Jonasova, A.
    LEUKEMIA RESEARCH, 2017, 55 : S56 - S57
  • [28] CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)
    Bello, Erica
    Pellagatti, Andrea
    Shaw, Jacqueline
    Mecucci, Cristina
    Kusec, Rajko
    Killick, Sally
    Giagounidis, Aristoteles
    Raynaud, Sophie
    Calasanz, Maria J.
    Fenaux, Pierre
    Boultwood, Jacqueline
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (02) : 210 - 214
  • [29] Interphase FISH Does Not Improve the Detection of DEL(5q) and DEL(20q) in Myelodysplastic Syndromes
    Douet-Guilbert, Nathalie
    Herry, Angele
    Le Bris, Marie-Josee
    Gueganic, Nadia
    Bovo, Clement
    Morel, Frederic
    De Braekeleer, Marc
    ANTICANCER RESEARCH, 2011, 31 (03) : 1007 - 1010
  • [30] MYELODYSPLASTIC SYNDROME WITH DEL(5Q) AND LENALIDOMIDE
    Gritsaev, S. V.
    Martinkevitch, I. S.
    Petrova, E. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (02): : 3 - 10
12345